Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-26
2011-07-26
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S630000
Reexamination Certificate
active
07985766
ABSTRACT:
The present invention describes a combination of an anticholinergic, such as R,R-glycopyrrolate, and a β mimetic, such as tormoterol, for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma.
REFERENCES:
patent: 6475467 (2002-11-01), Keller et al.
patent: 6645466 (2003-11-01), Keller et al.
patent: 2001/0027789 (2001-10-01), Goede et al.
patent: 2002/0115681 (2002-08-01), Bozung et al.
patent: 2002/0151597 (2002-10-01), Banerjee et al.
patent: 2003/0068280 (2003-04-01), Bannister et al.
patent: 2004/0002548 (2004-01-01), Bozung et al.
patent: WO 01/76575 (2001-10-01), None
patent: WO 02/078671 (2002-10-01), None
Cnota Peter Jurgen
Goede Joachim
Maus Joachim
Szelenyi Istvan
Hobbs Ann S.
MEDA Pharma GmbH & Co. KG
Spivack Phyllis G.
Venable LLP
LandOfFree
Combination of anticholineric and β mimetics for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of anticholineric and β mimetics for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of anticholineric and β mimetics for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679063